EWMA rescheduled to 23-25 May 2022
January 25, 2022
Despite the best intentions for bringing together the international wound community in Paris, it has become clear that the most prudent decision with respect to
News & Updates
News & Updates Overview
In this section we give you an overview of the latest news and updates regarding the development of DEBx Medical and our product DEBRICHEM. Follow us on LinkedIn for more up-to-date content!
Archives
DEBRICHEM® featured in the Wound Care section of Health Europa
December 15, 2021
Healthcare systems have been severely impacted by the COVID-19 pandemic, both in terms of workload and the resources, what has impacted patients who require treatment for
Press Release: DEBx Medical conference attendance for autumn 2021
September 28, 2021
Rotterdam, The Netherlands, September 28, 2021 – DEBx Medical, the Dutch medical technology company revolutionizing the management of chronic wounds, announced today that the Company
DEBx Medical presents at the Polish 2nd Online Wound Treatment conference
September 22, 2021
DEBx Medical is excited to present a special Biofilm session at the Polish 2nd Online Wound Treatment conference with Prof Gregory Schulz and B.J. Quint
DEBx Medical is attending the meeting of SPCPRE in Lisbon
September 15, 2021
DEBx Medical is attending the meeting of Soceidade Portuguesa de Cirurgia Plástica Reconstrutiva e Estetica, at Pestana Palace in Lisbon. Bert Quint, CEO will present on the
NBIC’s Biofilm Awareness Week: Biofilms in Non-Healing Wounds
August 20, 2021
About DEBx Medical My name is Bert Quint, I am the CEO and co-founder of DEBx Medical. In support of the first-ever biofilm awareness week,
DEBx Medical participates in the first-ever biofilm awareness week
August 3, 2021
Our partner, the National Biofilms Innovation Centre, announced that the first-ever awareness week dedicated to celebrating all things related to biofilms will take place from
Amputations: ‘A pandemic within the pandemic’
June 16, 2021
In our last article, we wrote about the impact of the COVID-19 pandemic on wound care and indicated how the use of DEBRICHEM® could provide
